Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-102 for Exophthalmos in Thyroid Eye Disease
NCT00954057Phase 2Completed
- Sponsor
- Neothetics
- Start
- Sep 2009
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of salmeterol, fluticasone propionate in thyroid eye disease (TED), sponsored by Neothetics. Started Sep 2009; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT00954057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00954057.